Pazonib 200 Mg (Pazopanib)

Description

About Pazonib 200 Mg

Each Pazonib 200 mg film-coated tablet contains 200 mg of Pazopanib in the form of Pazopanib HCI INN. A multi-tyrosine kinase inhibitor of vascular endothelial growth factor receptors is called palbociclib. Patients with advanced Renal Cell Carcinoma (RCC) and advanced Soft Tissue Sarcoma are prescribed pazonib 200 mg (STS). After receiving prior chemotherapy, Pazonib 200 mg is indicated for use in advanced STS patients.

Dosage

Pazonib 200 mg oral tablet recommended dosage is four tablets taken without food (at least an hour before or two hours after a meal). No more than four tablets should be taken each day as a dose. If there are less than 12 hours between doses, the missed dose shouldn’t be taken. With water, swallow the capsule whole. Never chew, open, or break the capsule. Pazonib 200 mg should be taken every day at about the same time.

Side Effects

• Hepatic Toxicity.
• Hypertension.
• Infection.
• Cardiac Dysfunction.
• Pneumonitis.
• Hypothyroidism.
• Proteinuria.

Storage

Pazonib 200 mg must be kept out of children’s reach, away from sunlight, and at or below 30°C in a dry, clean environment.